1-14 of 14
Matthew D. Galsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 562: Role of kinesin and Bcl-2 protein association in prostate cancer therapeutic resistance to taxane chemotherapy

Maddison Archer, Hamam Said, Sudeh Izadmehr, Nabila Zaman, Prerna R. Nepali, Goutam Chakraborty, Matthew D. Galsky, Wei Yang, Natasha Kyprianou
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 562.
https://doi.org/10.1158/1538-7445.AM2025-562
Published: 21 April 2025
View articletitled, Abstract 562: Role of kinesin and Bcl-2 protein association in prostate cancer therapeutic resistance to taxane chemotherapy
Journal Articles

Abstract CT023: Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Making a cold tumor hot

Sujit S. Nair, Dimple Chakravarty, Sreekumar Balan, Alexander Hakansson, Manuel Duval, Elai Davicioni, Yang Liu, Swati Bhardwaj, Tin Htwe Thin, Monica Garcia-barros, Kenneth Haines, Majd Al Shaarani, Rachel Weil, Marcia Meseck, Parita Ratnani, Monali Fatterpekar, Ivan Jambor, Elena Gonzalez-Gugel, Adam Farkas, Vinayak Wagaskar, Kacie Schlussel, Cristina Pasat-karasik, Kamala Bhatt, Zachary Dovey, Adriana Pedraza, Akriti Gupta, Dara Lundon, Ante Peros, Sneha Parekh, Lily Davenport, Xiangfu Zhang, Raghav Gupta, Macy Robison, Cynthia Knauer, Ethan Ellis, Dmitry Rykunov, Boris Reva, Babu Padanilam, Matthew D. Galsky, Rachel Brody, Mani Menon, Andres Salazar, Nina Bhardwaj, Ashutosh K. Tewari
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT023.
https://doi.org/10.1158/1538-7445.AM2024-CT023
Published: 05 April 2024
View articletitled, Abstract CT023: Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Making a cold tumor hot
Journal Articles

Abstract 1123: Genomic characterization of radiotherapy-associated bladder cancer

N. Ari Wijetunga, Kathryn H. Gessner, Krishna Kanchi, Sara E. Wobker, David Corcoran, Matthew D. Galsky, Matthew I. Milowsky, William Y. Kim, Tracy L. Rose, Jeffrey S. Damrauer
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1123.
https://doi.org/10.1158/1538-7445.AM2024-1123
Published: 22 March 2024
View articletitled, Abstract 1123: Genomic characterization of radiotherapy-associated bladder cancer
Journal Articles

Abstract 5648: Single cell spatial phenotyping of bladder tumors with a novel mechanism of NKG2A and HLA-E mediated resistance to BCG immunotherapy

Dmytro Klymyshyn, Niyati Jhaveri, Nadine Nelson, Michael Prater, Zhenqin Wu, Steven Hamel, Matthew D. Galsky, Nina Bhardwaj, John P. Sfakianos, Subham Basu, Oliver Braubach, Amir Horowitz
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5648.
https://doi.org/10.1158/1538-7445.AM2023-5648
Published: 04 April 2023
View articletitled, Abstract 5648: Single cell spatial phenotyping of bladder tumors with a novel mechanism of NKG2A and HLA-E mediated resistance to BCG immunotherapy
Journal Articles

Abstract CT042: Atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem in patients (pts) with previously untreated locally advanced or metastatic urothelial carcinoma (mUC): Updated overall survival (OS) from the randomized phase III study IMvigor130

Matthew D. Galsky, José Ángel Arranz, Enrique Grande, Maria De Santis, Ian D. Davis, Eiji Kikuchi, Xavier Garcia del Muro, Se Hoon Park, Ugo De Giorgi, Boris Alekseev, Marina Mencinger, Kouji Izumi, Javier Puente, Jian-Ri Li, Peter H. O'Donnell, Xiaodong Shen, Chooi Lee, Almut Mecke, Sanjeev Mariathasan, Aristotelis Bamias
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT042.
https://doi.org/10.1158/1538-7445.AM2021-CT042
Published: 01 July 2021
View articletitled, Abstract CT042: Atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem in patients (pts) with previously untreated locally advanced or metastatic urothelial carcinoma (mUC): Updated overall survival (OS) from the randomized phase III study IMvigor130
Journal Articles

Abstract CT040: Updated overall survival (OS) analysis of atezolizumab (atezo) monotherapy vs chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (mUC) in IMvigor130

Ian D. Davis, Matthew D. Galsky, Xavier Garcia del Muro, Se Hoon Park, Ugo De Giorgi, Boris Alekseev, Marina Mencinger, Kouji Izumi, Javier Puente, Jian-Ri Li, José Ángel Arranz, Aristotelis Bamias, Enrique Grande, Eiji Kikuchi, Almut Mecke, Sanjeev Mariathasan, Xiaodong Shen, Hannah (Xinhui) Huang, Maria De Santis
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT040.
https://doi.org/10.1158/1538-7445.AM2021-CT040
Published: 01 July 2021
View articletitled, Abstract CT040: Updated overall survival (OS) analysis of atezolizumab (atezo) monotherapy vs chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (mUC) in IMvigor130
Journal Articles

Abstract CT187: Overall survival (OS) by response during “induction” from the global, randomized Phase III IMvigor130 study of atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem in patients (pts) with previously untreated metastatic urothelial carcinoma (mUC)

Enrique Grande, Aristotelis Bamias, Matthew D. Galsky, Eiji Kikuchi, Ian D. Davis, José Ángel Arranz, Arash Rezazadeh Kalebasty, Xavier Garcia del Muro, Se Hoon Park, Ugo De Giorgi, Boris Alekseev, Marina Mencinger, Kouji Izumi, Javier Puente, Jian-Ri Li, Xiaodong Shen, Beiying Ding, Qian Zhu, Jeremy Linsenmeier, Maria De Santis
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT187.
https://doi.org/10.1158/1538-7445.AM2021-CT187
Published: 01 July 2021
View articletitled, Abstract CT187: Overall survival (OS) by response during “induction” from the global, randomized Phase III IMvigor130 study of atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem in patients (pts) with previously untreated metastatic urothelial carcinoma (mUC)
Journal Articles

Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts

Timothy A Yap, Panagiotis Konstantinopoulos, Melinda L. Telli, Smita Saraykar, J Thaddeus Beck, Matthew D. Galsky, Jame Abraham, David R. Wise, Mustafa Khasraw, Gabor Rubovszky, Mikhail Dvorkin, Anil A Joy, Mateusz Opyrchal, Daria Stypinski, Colombe Chappey, Ross Stewart, Rossano Cesari, Anita Scheuber, Aditya Bardia
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P1-19-03.
https://doi.org/10.1158/1538-7445.SABCS19-P1-19-03
Published: 15 February 2020
View articletitled, Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts
Journal Articles

Abstract 4890: Mutational signatures as biomarkers of response to nivolumab in metastatic bladder cancer

G. Celine Han, Peter M. Szabo, Abdel Saci, Alice M. Walsh, Natallia Kalinava, Ariella Sasson, Bruce Fischer, Matthew D. Galsky, Padmanee Sharma
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4890.
https://doi.org/10.1158/1538-7445.AM2019-4890
Published: 01 July 2019
View articletitled, Abstract 4890: Mutational signatures as biomarkers of response to nivolumab in metastatic bladder cancer
Journal Articles

Abstract CT178: Nivolumab monotherapy in patients with advanced platinum-resistant urothelial carcinoma: Efficacy and safety update and association between biomarkers and overall survival in CheckMate 275

Padmanee Sharma, Ari Baron, Andrea Necchi, Elizabeth R. Plimack, Sumanta K. Pal, Jens Bedke, Jose A. Arranz, Daniel Vaena, Marc-Oliver Grimm, Sergio Bracarda, Margitta Retz, Arlene Siefker-Radtke, Chikara Ohyama, Gary Grossfeld, Haolan Lu, Abdel Saci, Hao Tang, Matthew D. Galsky
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT178.
https://doi.org/10.1158/1538-7445.AM2018-CT178
Published: 01 July 2018
View articletitled, Abstract CT178: Nivolumab monotherapy in patients with advanced platinum-resistant urothelial carcinoma: Efficacy and safety update and association between biomarkers and overall survival in CheckMate 275
Journal Articles

Abstract 4745: Tim-3 and TIGIT mark NK and T cells susceptible to effector dysfunction in human bladder cancer

Adam M. Farkas, Francois Audenet, Harry Anastos, William K. Oh, Matthew D. Galsky, John P. Sfakianos, Nina Bhardwaj
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4745.
https://doi.org/10.1158/1538-7445.AM2018-4745
Published: 01 July 2018
View articletitled, Abstract 4745: Tim-3 and TIGIT mark NK and T cells susceptible to effector dysfunction in human bladder cancer
Journal Articles

Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer

Kimberly McClinch, Rita A. Avelar, David Callejas, Sudeh Izadmehr, Danica Wiredja, Abbey Perl, Jaya Sangodkar, David B. Kastrinsky, Daniela Schlatzer, Maxwell Cooper, Janna Kiselar, Agnes Stachnik, Shen Yao, Divya Hoon, Daniel McQuaid, Nilesh Zaware, Yixuan Gong, David L. Brautigan, Stephen R. Plymate, Cynthia C.T. Sprenger, William K. Oh, Alice C. Levine, Alexander Kirschenbaum, John P. Sfakianos, Rosalie Sears, Analisa DiFeo, Yiannis Ioannou, Michael Ohlmeyer, Goutham Narla, Matthew D. Galsky
Journal: Cancer Research
Cancer Res (2018) 78 (8): 2065–2080.
https://doi.org/10.1158/0008-5472.CAN-17-0123
Published: 12 April 2018
View articletitled, Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer
Open the PDF for Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 368: Inferred regulatory interaction network from prostate cancer reveals potential regulators coordinating progression and metastasis

Xudong Dai, Yixuang Gong, Matthew D. Galsky, Eric E. Schadt, William K. Oh, Jun Zhu
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 368.
https://doi.org/10.1158/1538-7445.AM2014-368
Published: 01 October 2014
View articletitled, Abstract 368: Inferred regulatory interaction network from prostate cancer reveals potential regulators coordinating progression and metastasis
Journal Articles

Abstract 1098: TIMP-1: A potential biomarker of neuroendocrine differentiation in metastatic castration-resistant prostate cancer (mCRPC)

Yixuan Gong, Uma Chippada-Venkata, Xudong Dai, Matthew D. Galsky, Jiaoti Huang
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1098.
https://doi.org/10.1158/1538-7445.AM2014-1098
Published: 01 October 2014
View articletitled, Abstract 1098: TIMP-1: A potential biomarker of neuroendocrine differentiation in metastatic castration-resistant prostate cancer (mCRPC)